ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional

Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT03988595

Public ClinicalTrials.gov record NCT03988595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 9:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Trial of Exercise Treatment With Concurrent First-Line Therapy for Hormone Receptor Positive Metastatic Breast Cancer

Study identification

NCT ID
NCT03988595
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
54 participants

Conditions and interventions

Interventions

  • Exercise Treatment Other

Other

Eligibility (public fields only)

Age range
19 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2019
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update posted
Aug 26, 2025

2019 – 2026

United States locations

U.S. sites
10
U.S. states
4
U.S. cities
10
Facility City State ZIP Site status
Indiana University (Data Collection Only) Indianapolis Indiana 46202
Johns Hopkins Hospital (Data Collection Only) Baltimore Maryland 21287
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645
Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity) Commack New York 11725
Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York 10604
Memorial Sloan Kettering Cancer Center New York New York 10065
Montefiore Health Systems (Montefiore Medical Center) (Data Collection Only) The Bronx New York 10467
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03988595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03988595 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →